Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation.

Resistance to aminoglycosides prevailed the most before and after HSCT (12/11/10), followed by tetracyclines (11/7/4), which exhibited a decreasing trend. β-lactam (8/8/8) and macrolide resistance (9/9/9) were consistently present in gut microbiota, together with lincosamides (10/10/9), streptogramin b (9/9/10), and folate pathway antagonist (11/8/8).

also in 47,180 other papers